Ghai Shruti, Shrestha Rejina, Su Kuo-Hui
Department of Cell and Cancer Biology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, United States.
Front Cell Dev Biol. 2025 Jan 9;12:1500880. doi: 10.3389/fcell.2024.1500880. eCollection 2024.
Heat Shock Factor 1 (HSF1) is a major transcriptional factor regulating the heat shock response and has become a potential target for overcoming cancer chemoresistance. This review comprehensively examines HSF1's role in chemoresistance and its potential as a therapeutic target in cancer. We explore the complex, intricate mechanism that regulates the activation of HSF1, HSF1's function in promoting resistance to chemotherapy, and the strategies used to manipulate HSF1 for therapeutic benefit. In addition, we discuss emerging research implicating HSF1's roles in autophagy, apoptosis, DNA damage repair, drug efflux, and thus chemoresistance. This article highlights the significance of HSF1 in cancer chemoresistance and its potential as a target for enhancing cancer treatment efficacy.
热休克因子1(HSF1)是调节热休克反应的主要转录因子,已成为克服癌症化疗耐药性的潜在靶点。本综述全面研究了HSF1在化疗耐药中的作用及其作为癌症治疗靶点的潜力。我们探讨了调节HSF1激活的复杂机制、HSF1在促进化疗耐药中的功能,以及为获得治疗益处而操纵HSF1的策略。此外,我们还讨论了有关HSF1在自噬、细胞凋亡、DNA损伤修复、药物外排以及化疗耐药中作用的新兴研究。本文强调了HSF1在癌症化疗耐药中的重要性及其作为提高癌症治疗疗效靶点的潜力。